BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Clofibrate
,
rs7903146
,
FXYD4
,
Coagulation
,
Pseudomonas infection
,
Lung
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
epstein- barr virus
Summary
General Info
Curated Studies
Most Correlated Studies
LMP1 mediated gene expression changes in transfected CD10+ GC B cells
Burkitt lymphoma DG-75 cells expressing EBV LMP1 and treated with olaparib
B-lymphocytes from adenoids were infected with wt/B95-8 or deltamiR Epstein-Barr virus strains
Epstein-Barr virus-positive gastric carcinoma cell lines and primary biopsy samples
CD8+ T cells during acute and convalescent phase of EBV infection
Explore Curated Studies Results
Literature
Most Relevant Literature
Histone methylation in Epstein-Barr virus-associated diseases.
Targeting EBV-encoded products: Implications for drug development in EBV-associated diseases.
Treatment of Epstein-Barr Virus infection in immunocompromised patients.
EBV-microRNAs as Potential Biomarkers in EBV-related Fever: A Narrative Review.
The novel immune landscape of immune-checkpoint blockade in EBV-associated malignancies.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Ha…
Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma
Immunodeficiency for Severe Epstein-Barr Virus Infection
Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Viru…
Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ